Ghost-authors, improvement article communication, and medical publications

Fugh-Berman, 2010, The haunting of medical journals: how ghostwriting sold “HRT”, PLoS Med, 9, e1000335, 10.1371/journal.pmed.1000335 Laine, 2005, Exorcising ghosts and unwelcome guests, Ann Intern Med, 143, 611, 10.7326/0003-4819-143-8-200510180-00013 1993, Ghost with a chance in publishing undergrowth, Lancet, 342, 1498, 10.1016/S0140-6736(05)80075-3 Moffatt, 2007, Ghost marketing: pharmaceutical companies and ghostwritten journal articles, Perspect Biol Med, 50, 18, 10.1353/pbm.2007.0009 Ross, 2008, Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation, JAMA, 299, 1800, 10.1001/jama.299.15.1800 DeAngelis, 2008, Impugning the integrity of medical science: the adverse effects of industry influence, JAMA, 299, 1833, 10.1001/jama.299.15.1833 Lagnado, 2003, Increasing the trust in scientific authorship, Br J Psychiatry, 183, 3, 10.1192/bjp.183.1.3 Bevan, 2002, Ethical behaviour of authors in biomedical journalism, Ann R Coll Physicians Surg Can, 35, 81 Bodenheimer, 2000, Uneasy alliance — clinical investigators and the pharmaceutical industry, N Engl J Med, 342, 1539, 10.1056/NEJM200005183422024 Schulman, 2002, A national survey of provisions in clinicaltrial agreements between medical schools and industry sponsors, N Engl J Med, 347, 1335, 10.1056/NEJMsa020349 Halperin, 2005, Conforming to ICMJE principles, CMAJ, 173, 1358, 10.1503/cmaj.1050172 Fugh-Berman, 2005, The corporate coauthor, J Gen Intern Med, 20, 546, 10.1111/j.1525-1497.2005.05857.x S Matias-Guiu, 2011, Sesgos en la edición de las publicaciones científicas, Neurologia Daskalopoulou, 2005, The involvement of professional medical writers in medical publications, Curr Med Res Opin, 21, 307, 10.1185/030079905X28944 Iniesta, 2010, Neurology and literature, Neurologia, 25, 507, 10.1016/j.nrl.2010.07.013 2000, Who is an author?, Science Editor, 23, 111 Angell, 2000, The pharmaceutical industry — to whom is it accountable?, N Engl J Med., 342, 1902, 10.1056/NEJM200006223422509 Healy, 2003, Interface between authorship, industry and science in the domain of therapeutics, Br J Psych, 183, 22, 10.1192/bjp.183.1.22 Djulbegovic, 2000, The uncertainty principle and industry-sponsored research, Lancet, 356, 635, 10.1016/S0140-6736(00)02605-2 Ngai, 2005, Haunted manuscripts: ghost authorship in the medical literature, Account Res, 12, 103, 10.1080/08989620590957175 Fugh-Berman, 2008, The ethics of publication planning in the pharmaceutical industry, Open Medicine, 02, 33 Fugh-Berman, 2008, Off-label promotion, on-target sales, PLoS Med, 5, 210, 10.1371/journal.pmed.0050210 Sismondo, 2007, Ghost management: how much of the medical literature is shaped behind the scenes by the pharmaceutical industry?, PLoS Med, 4, 286, 10.1371/journal.pmed.0040286 Jacobs, 2004, Transparency and trust: in defence of medical writers, BMJ, 329, 1345, 10.1136/bmj.329.7478.1345-a Hamilton, 2010, Don’t get spooked! How to collaborate with a professional medical communicator (and avoid ghostwriting), Arch Immunol Ther Exp (Warsz), 58, 255, 10.1007/s00005-010-0080-3 Jacobs, 2005, The involvement of professional medical writers in medical publications: results of a Delphi study, Curr Med Res Opin, 21, 311, 10.1185/030079905X25569 Shashok, 2008, Content and communication: how can peer review provide helpful feedback about the writing?, BMC Med Res Methodol, 31, 3, 10.1186/1471-2288-8-3 Shashok, 1997, Responsabilidades compartidas en la revisión de los originales por expertos, Rev Neurol, 148, 1946 Matías-Guiu, 2010, The profile of evaluators of a medical publication in relation to the response, Neurologia, 25, 530, 10.1016/j.nrl.2010.03.012 Matias-Guiu, 2009, El proceso de mejora y decisión de un artículo, Neurologia, 24, 353 Shashok, 2001, Author's editors: facilitators of science information transfer, Learned Publishing, 14, 113, 10.1087/095315101300059495 Hartley, 2007, Lost in translation: Contributions of editors to the meanings of text, J Information Sci, 33, 551, 10.1177/0165551506076392 Horton, 1995, The rhetoric of research, BMJ, 310, 985, 10.1136/bmj.310.6985.985 Freeman, 2006, The publishing gap between rich and poor: the focus of Author aid, J Public Health Policy, 27, 196, 10.1057/palgrave.jphp.3200071 Gøtzsche, 2009, What should be done to tackle ghostwriting in the medical literature?, PLoS Med, 06, 23, 10.1371/journal.pmed.1000023 Norris, 2007, International Society for Medical Publication Professionals (ISMPP) position statement: the role of the professional medical writer, Curr Med Res Opin, 23, 1837, 10.1185/030079907X210642 Matias-Guiu, 2010, Fraude y conductas inapropiadas en las publicaciones científicas, Neurologia, 25, 1, 10.1016/S0213-4853(10)70015-3 Ray, 2002, Judging the judges: the role of journal, QJM, 95, 769, 10.1093/qjmed/95.12.769 Shahok, 2007, Who's watching whose ethics? Slanted reportig of the medical writer's role in the Neuropsychopharmacology- Ciberonics Case 1, The Write Stuff, 16, 1 Jacobs, 2005, European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications, Curr Med Res Opin, 21, 317, 10.1185/030079905X25578 Wager, 2003, Good publication practice for pharmaceutical companies, Curr Med Res Opin, 19, 149, 10.1185/030079903125001767 Fugh-Berman, 2006, Gynecologists and estrogen: an affair of the heart, Perspect Biol Med, 49, 115, 10.1353/pbm.2006.0006 Dowsett, 2010, Developing good scientific publishing practices: one pharmaceutical company's perspective, Curr Med Res Opin, 26, 1249, 10.1185/03007991003748880 Gøtzsche, 2007, Ghost authorship in industry-initiated randomised trials, PLoS Med, 4, e535, 10.1371/journal.pmed.0040019 Wager, 2007, Authors, ghosts, damned lies, and statisticians, PLoS Med, 4, e34, 10.1371/journal.pmed.0040034 Lacasse, 2010, Ghostwriting at elite academic medical centers in the United States, Plos Med, 7, e1000230, 10.1371/journal.pmed.1000230 Górski, 2010, “Medical writing” and ghostwriting as ethical challenges in medical communication, Transplant Proc, 42, 3335, 10.1016/j.transproceed.2010.07.023 McHenry, 2008, Industry-Sponsored Ghostwriting in Clinical Trial Reporting: A Case Study, Accountability Res, 15, 152, 10.1080/08989620802194384 Landefeld, 2009, The Neurontin legacy - marketing through misinformation and manipulation, NEJM, 360, 103, 10.1056/NEJMp0808659 Sismondo, 2009, Ghosts in the machine: publication planning in the medical sciences, Soc Stud Sci, 39, 171, 10.1177/0306312708101047 Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication. Available from: www.icmje.org. Peh, 2009, Authorship and acknowledgements, Singapore Med J, 50, 563 Matías-Guiu, 2009, Autor y autoría en las publicaciones médicas, Neurología, 24, 1 Schultz, 2007, Transparency is the key to the relationship between biomedical journals and medical writers, Invest Dermatol, 127, 735, 10.1038/sj.jid.5700794 Garrow, 1998, The reported training and experience of editors in chief of specialist clinical medical journals, JAMA, 280, 286, 10.1001/jama.280.3.286 Matías-Guiu, 2010, Independencia editorial, Neurologia, 25, 339, 10.1016/j.nrl.2010.03.003 Matías-Guiu, 2008, El factor de impacto y las decisiones editoriales, Neurología, 23, 342 Angell, 1986, Publish or perish: a proposal, Ann Intern Med, 104, 261, 10.7326/0003-4819-104-2-261 Urbano, 2001, El análisis de citas de trabajos de investigadores como método para el estudio del uso de información en bibliotecas, An Docum, 4, 243 Vivas, 1991, Análisis bibliométrico de la actividad investigadora de la industria farmacéutica española, Farm Clin, 8, 768 Mowatt, 2002, Prevalence of honorary and ghost authorship in Cochrane reviews, JAMA, 287, 2769, 10.1001/jama.287.21.2769